Skip to main content
. 2020 Jul 6;28(2):1238–1246. doi: 10.1245/s10434-020-08813-y

Fig. 2.

Fig. 2

Survival analysis of Xp11.2 translocation renal cell carcinoma with comparison between radical nephrectomy and nephron-sparing surgery subgroups: a overall and b progression-free survival of patients with cT1a tumor; c overall and d progression-free survival of patients with cT1b tumor; and e overall and f progression-free survival of patients both with cT1a and cT1b tumor